We found that CPT increased ET-1 mRNA in HCT p53+/+ cells, but not p53−/− cells, although the increase observed was not as significant as that seen in ccRCC cells (Figure 4b). The gene discussed is TP53; the disease is nonpapillary renal cell carcinoma.